Nexalin Technology regains compliance with Nasdaq's minimum bid price requirement, focusing on mental health.

From GlobeNewswire: 2024-11-01 10:34:00

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) announced it has regained compliance with Nasdaq’s minimum bid price requirement. CEO Mark White expressed gratitude to shareholders for their support as the company works on neurostimulation treatments for mental health disorders. Nexalin designs non-invasive neurostimulation products to address global mental health challenges, with their Gen-2 device approved in China, Brazil, and Oman. The company’s forward-looking statements highlight their commitment to driving shareholder value and advancing clinical research for neurological disorders. For more information, visit https://nexalin.com/ or contact Crescendo Communications, LLC or RedChip Companies Inc.



Read more at GlobeNewswire: Nexalin Technology Regains Compliance with Nasdaq Continued